Clarius Group, LLC Pfizer Inc Transaction History

Clarius Group, LLC

$1.55 Billion
Q1 2025

A detailed history of Clarius Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Clarius Group, LLC holds 19,001 shares of PFE stock, worth $448,613. This represents 0.03% of its overall portfolio holdings.

Number of Shares

19,001

Previous 30,747 38.2%

Holding current value

$448,613

Previous $815,000 40.98%

% of portfolio

0.03%

Previous 0.06%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 18, 2025	SELL	$25.01 - $27.13 $293,767 - $318,668	-11,746 Reduced 38.2%	19,001 $481,000
Q4 2024 Jan 15, 2025	BUY	$24.8 - $30.19 $105,400 - $128,307	4,250 Added 16.04%	30,747 $815,000
Q3 2024 Oct 09, 2024	SELL	$27.7 - $31.39 $60,940 - $69,058	-2,200 Reduced 7.67%	26,497 $766,000
Q2 2024 Jul 11, 2024	SELL	$25.26 - $29.6 $81,539 - $95,548	-3,228 Reduced 10.11%	28,697 $802,000
Q1 2024 Apr 17, 2024	SELL	$25.89 - $29.73 $111,585 - $128,136	-4,310 Reduced 11.89%	31,925 $885,000
Q4 2023 Jan 29, 2024	SELL	$26.13 - $33.94 $271,020 - $352,025	-10,372 Reduced 22.25%	36,235 $1.04 Million
Q3 2023 Oct 19, 2023	SELL	$32.09 - $37.51 $342,560 - $400,419	-10,675 Reduced 18.64%	46,607 $1.55 Million
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $31,496 - $36,440	-872 Reduced 1.5%	57,282 $2.1 Million
Q1 2023 Apr 17, 2023	SELL	$39.39 - $51.28 $179,815 - $234,093	-4,565 Reduced 7.28%	58,154 $2.37 Million
Q4 2022 Jan 25, 2023	BUY	$41.75 - $54.5 $1,878 - $2,452	45 Added 0.07%	62,719 $3.21 Million
Q3 2022 Oct 24, 2022	BUY	$43.76 - $53.42 $243,261 - $296,961	5,559 Added 9.73%	62,674 $2.74 Million
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $156,526 - $185,591	3,364 Added 6.26%	57,115 $3 Million
Q4 2021 Feb 02, 2022	BUY	$41.32 - $61.25 $121,770 - $180,503	2,947 Added 5.8%	53,751 $3.17 Million
Q3 2021 Oct 18, 2021	BUY	$39.25 - $50.42 $40,702 - $52,285	1,037 Added 2.08%	50,804 $2.19 Million
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $213,413 - $241,761	5,943 Added 13.56%	49,767 $1.95 Million
Q1 2021 Apr 27, 2021	SELL	$33.49 - $37.77 $242,132 - $273,077	-7,230 Reduced 14.16%	43,824 $1.59 Million
Q4 2020 Jan 15, 2021	BUY	$33.47 - $42.56 $350,430 - $445,603	10,470 Added 25.8%	51,054 $1.88 Million
Q3 2020 Oct 09, 2020	SELL	$31.75 - $37.25 $14,128 - $16,576	-445 Reduced 1.08%	40,584 $1.49 Million
Q2 2020 Jul 08, 2020	BUY	$30.12 - $36.54 $41,625 - $50,498	1,382 Added 3.49%	41,029 $1.34 Million
Q1 2020 Apr 24, 2020	BUY	$27.03 - $38.62 $72,359 - $103,385	2,677 Added 7.24%	39,647 $1.29 Million
Q4 2019 Jan 22, 2020	BUY	$32.92 - $37.36 $6,946 - $7,882	211 Added 0.57%	36,970 $1.5 Million
Q3 2019 Oct 23, 2019	BUY	$32.49 - $42.13 $290,655 - $376,894	8,946 Added 32.16%	36,759 $1.32 Million
Q2 2019 Aug 02, 2019	SELL	$36.98 - $41.52 $109,312 - $122,733	-2,956 Reduced 9.61%	27,813 $1.21 Million
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $490,500 - $538,896	13,080 Added 73.94%	30,769 $1.31 Million
Q4 2018 Feb 11, 2019	BUY	$38.47 - $43.86 $173,268 - $197,545	4,504 Added 34.16%	17,689 $772,000
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $454,486 - $551,264	13,185 New	13,185 $581,000

Others Institutions Holding PFE

# of Institutions

3,365

Shares Held

3.6B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $133B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Account

Clarius Group, LLC Pfizer Inc Transaction History